How the Pharmaceutical Industry is Tackling Scope 3 Emissions

January 4, 2022

The Energize supply chain decarbonization program brings together leading pharmaceutical companies to collaborate on reducing their Scope 3 emissions and mitigating the overall environmental impact of the pharmaceutical industry. By working with Schneider Electric and other leading pharmaceutical companies, Energize aims to assist pharmaceutical suppliers in adopting renewable energy by providing education and removing market barriers.

In this video, representatives from two pharmaceutical companies participating in this program, GSK and Novartis, talk about the goal of the program and the potential for this model to be scaled to other sectors.

Previous Article
NSG Group Introduces Renewable Electricity in Poland
NSG Group Introduces Renewable Electricity in Poland

NSG UK Enterprises, part of the NSG Group, has signed a power purchase agreement (PPA) for the renewable el...

Next Video
2021 CDP Reporting Outcomes and Predictions for 2022
2021 CDP Reporting Outcomes and Predictions for 2022

Our sustainability experts share findings on the 2021 CDP scores, including insights from our clients and w...

On-Demand WEBINAR

Climate Action 2021:
The Year of Breakthroughs?

ACCESS NOW